Convalescent Plasma Treatment in Severe 2009 H1N1 Infection
NCT01306773
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Influenza A
Interventions
DRUG:
H1N1 convalescent plasma and oseltamivir
DRUG:
Oral Oseltamivir alone
Sponsor
The University of Hong Kong